NDC 36987-1236

Oyster

Oyster

Oyster is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Oyster.

Product ID36987-1236_2266ee8c-c745-471e-845a-267f11a1c269
NDC36987-1236
Product TypeHuman Prescription Drug
Proprietary NameOyster
Generic NameOyster
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1972-08-29
Marketing CategoryBLA / BLA
Application NumberBLA102192
Labeler NameNelco Laboratories, Inc.
Substance NameOYSTER
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Shellfish Proteins [EXT]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 36987-1236-1

5 mL in 1 VIAL, MULTI-DOSE (36987-1236-1)
Marketing Start Date1972-08-29
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 36987-1236-4 [36987123604]

Oyster INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-1236-3 [36987123603]

Oyster INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-1236-1 [36987123601]

Oyster INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

NDC 36987-1236-2 [36987123602]

Oyster INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102192
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1972-08-29
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
OYSTER.1 g/mL

OpenFDA Data

SPL SET ID:ed374a8c-81d6-4389-b77b-00e5517ada89
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 905479
  • 892506
  • 905345
  • 892564
  • 904543
  • 901282
  • 892595
  • 892546
  • 966805
  • 899433
  • 966978
  • 901375
  • 904599
  • 901290
  • 899751
  • 899937
  • 905489
  • 901397
  • 905329
  • 892542
  • 905365
  • 892613
  • Pharmacological Class

    • Non-Standardized Food Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Allergens [CS]
    • Dietary Proteins [CS]
    • Shellfish Proteins [EXT]

    NDC Crossover Matching brand name "Oyster" or generic name "Oyster"

    NDCBrand NameGeneric Name
    0268-6189OYSTEREASTERN OYSTER
    22840-5774OysterCrassostrea virginica
    36987-1234OysterOyster
    36987-1235OysterOyster
    36987-1236OysterOyster
    36987-1237OysterOyster
    49288-0336OysterOyster

    Trademark Results [Oyster]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    OYSTER
    OYSTER
    98716017 not registered Live/Pending
    Ruth Johnson
    2024-08-25
    OYSTER
    OYSTER
    98377030 not registered Live/Pending
    Oyster LLC
    2024-01-26
    OYSTER
    OYSTER
    98303834 not registered Live/Pending
    OYSTER PRODUCTS LLC
    2023-12-07
    OYSTER
    OYSTER
    98299848 not registered Live/Pending
    Oyster Technologies, Inc.
    2023-12-05
    OYSTER
    OYSTER
    98299844 not registered Live/Pending
    Oyster Technologies, Inc.
    2023-12-05
    OYSTER
    OYSTER
    97705661 not registered Live/Pending
    Craif Inc.
    2022-12-06
    OYSTER
    OYSTER
    97658064 not registered Live/Pending
    Nth Cycle, Inc.
    2022-11-01
    OYSTER
    OYSTER
    97658039 not registered Live/Pending
    Nth Cycle, Inc.
    2022-11-01
    OYSTER
    OYSTER
    97587429 not registered Live/Pending
    OYSTER HR, INC.
    2022-09-12
    OYSTER
    OYSTER
    97121432 not registered Live/Pending
    Oyster
    2021-11-12
    OYSTER
    OYSTER
    97023795 not registered Live/Pending
    The Sugar Art
    2021-09-13
    OYSTER
    OYSTER
    90825057 not registered Live/Pending
    iM Global Partner Asset Management S.A.
    2021-07-13

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.